Showing results (1-10 of 180) with videos related to
Sort By:
Pageof 18
Hormone Research in Paediatrics|March 19, 2019
Hypothalamic Obesity: Prologue and PromiseM Jennifer Abuzzahab, Christian L Roth, Ashley H ShoemakerDiabetes, Obesity & Metabolism|March 2, 2021
MRI measures of hypothalamic injury are associated with glucagon-like peptide-1 receptor agonist treatment response in people with hypothalamic obesityFrancisco A Perez, Clinton Elfers, Jack A Yanovski, et al.The Lancet. Diabetes & Endocrinology|May 2, 2024
Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trialChristian L Roth, Cecilia Scimia, Ashley H Shoemaker, et al.Diabetes, Obesity & Metabolism|October 7, 2020
A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesityChristian L Roth, Francisco A Perez, Kathryn B Whitlock, et al.International Journal of Obesity (2005)|January 3, 2022
Energy balance in hypothalamic obesity in response to treatment with a once-weekly GLP-1 receptor agonistAshley H Shoemaker, Heidi J Silver, Maciej Buchowski, et al.Hormone Research in Paediatrics|July 27, 2012
Treatment with glucagon-like Peptide-1 agonist exendin-4 in a patient with hypothalamic obesity secondary to intracranial tumorJill H Simmons, Ashley H Shoemaker, Christian L RothInternational Journal of Pediatric Endocrinology|October 23, 2014
Eating behaviors in obese children with pseudohypoparathyroidism type 1a: a cross-sectional studyLulu Wang, Ashley H ShoemakerPageof 18